of detecting co-infections and can revealunexpected pathogens. Here we describe a

University. We initially demonstrated that purine 2', 3' dideoxynucleosides were... expressing HBV (5). We demonstrated its activity against HBV in 

and foreign scientists from all over the world. We also aim to encourage

of the committee, we sincerely hope primary discussions, topics and invitees would come across... partnership with top China CRO,biotech and academia4.Hear how government

LEEP 术对应于 IFCPC 中 1 型或 2 型切除（1 型 = 完全可见的 SCJ; 2 型 = 不完全可见的 SCJ），而 top-hat LEEP...:How Do We Perform Colposcopy? Implications for Establishing Standards. J Low

健康类新媒体「恩哥聊健康」，快手健康「看见医生·直播榜」TOP 1，全网点击近 8 亿。复旦大学附属妇产科医院主任医师，妇科内分泌与生殖医学科副主任，硕士研究生导师，妇产科学临床医学博士。致力于医学科普，创建个人科普公众号：《恩哥聊健康》

。该项PTSD远程医疗延伸项目（TOP）采用随机有效性试验设计和意向治疗分析。共招募265例退伍军人，随机分配接受常规护理或TOP干预，随访时间为12个月。主要...整个团队，并对患者在交互式视频中提出的咨询进行解答。结果显示，与常规护理组患者相比，6个月时TOP组患者的创伤后诊断量表评分显著下降；12个月时，TOP组患者的

;会议背景介绍： On behalf of the organizing committee, we welcome you

not been well studied. We investigated plasma tau by using an immunomagnetic reduction... set of cognitive function test. We explored their relationships with both brain

;-thalassemia (thal) mutations of the Li people in Hainan Province of China.We have...% carry both α-thal and β-thal mutations. We also examined 9800 subjects

aneurysm.We performed an extensive literature search from 1960 to 2011... factors of aneurysm growth and rupture have been identified. We provide

to emerge that peripheral clocks talk to each other and back to the SCN. As we begin..., so we will begin to elucidate the roles of fine adjusters, such as hormones

critical functions across various biological processes(1,2). Here we use a new... the developmental lineage and differentiation state of the tumours. We observe a

We will feature many opportunities to enhance interactions between students... traditional and core topics. We welcome proposals of special topics that reflect

and vitality.We aresure that you will enjoy your stay in Beijingfrom gaining... with yourcontribution that we can ensure the success of AMS 2014.We lookforward

long way since December 2011 when we met in Adelaide for the Fourth...) as we add information (see Important Dates). To receive future notices, online

of gastroenterology.In parallel with our professional endeavors, we will also enjoy... professionals, and industry-sponsored symposia. We look forward to meeting with you

long way since December 2011 when we met in Adelaide for the Fourth... this website (http://dnabarcodes2013.org or http://dnabarcodes2013.csp.escience.cn) as we

congress, we are not only focused on the imminent problems of epidemics, cares... break through and advances in the field.We have invited numbers of world’

Background. Further reduction in the group B streptococcal (GBS) disease burden in neonates in the United States awaits an additional prevention strategy, such as maternal immunization.Methods. We performed a prospective, multicenter, case-control study of 33 mothers delivering neonates with early onset GBS infection (cases), and 99 age- and ethnicity-matched mothers colonized with the same capsular polysaccharide (CPS) types delivering healthy neonates (controls). Relative risk and absolute risk were calculated for early onset disease associated with concentrations of type Ia, III, or V CPS-specific antibody in maternal serum.Results. For GBS types Ia and III, maternal CPS-specific antibody concentrations of ≥0.5 µg/mL were associated with a relative risk of approximately 0.1 (95% confidence intervals [CIs], .01-.74 and 0-.72, respectively; P = .02 for each), corresponding to a 90% risk reduction (by logistic regression). For type V, the relative risk was 0.3 (95% CI, .01-3.1), corresponding to a 70% risk reduction. By Bayesian modeling, the risk of early onset disease would decrease by 70% if maternal CPS-specific antibody concentrations for these 3 GBS types were ≥1 µg/mL.Conclusions. Maternal CPS-specific antibody serum concentrations of ≥1 μg/mL at the time of delivery appear to protect most neonates from early onset GBS type Ia and III disease.